What is Benitec Biopharma Inc. (BNTC)?
Benitec Biopharma Inc. is a biotechnology company specializing in the development of gene-based therapies. The company focuses on utilizing gene silencing technologies, including RNA interference and DNA-directed RNA interference, to address chronic and life-threatening diseases. Its research and development efforts target conditions such as hepatitis B, ocular diseases, and other genetic disorders. Benitec Biopharma collaborates with academic institutions and industry partners to advance its therapeutic candidates through preclinical and clinical stages. The company aims to harness novel molecular approaches to modulate gene expression, offering potential treatment options where traditional therapies may be limited. Headquartered in Australia, Benitec Biopharma operates within the global biopharmaceutical sector, contributing to the evolving landscape of genetic medicine. Its scientific platform is built on proprietary technologies designed to improve the specificity and durability of gene silencing effects. The company’s activities encompass research, development, and potential commercialization of innovative therapies based on nucleic acid technologies.
Benitec Biopharma Inc. Stock Price Today: Live Overview
The price today is shaped by active trading, with Benitec Biopharma Inc. holding at $11.1114. The price has ranged from $10.8086 to $11.4686 during today’s session, with a daily change of 0%.
FAQ: Benitec Biopharma Inc. (BNTC)
What is the current price of BNTC stock?
Benitec Biopharma Inc. closed at $11.1114 today.
Does BNTC pay dividends?
The company pays dividends via cash distributions (if applicable).
Does BNTC have a formal corporate presence or regional headquarters in the UAE?
Benitec Biopharma Inc. operates via partners and distributors in the UAE without an official regional office or subsidiary.
What is BNTC best known for?
Benitec Biopharma Inc. is most famous for its work in gene silencing therapeutics.
What assets are typically shown together with BNTC?
Commonly shown alongside BNTC: Neurocrine, MediWound Ltd, Hafnia Ltd
Latest shares articles



